The year 2025 confirmed the IEM CAS’s high publication performance. The institute’s scientific teams published 79 papers, with an overall impact factor of 560.1 (average 7.09).
In terms of the number of papers, the most active departments were:
- Department of Toxicology and Molecular Epidemiology (23 publications),
- Department of Neuroregeneration (17 publications),
- Department of Molecular Biology of Cancer (11 publications).
The above quantitative indicators do not, in themselves, reflect the overall scientific impact and quality of individual publications and are for informational purposes only – as an indicative overview of publishing activity. In this context, however, they highlight the IEM CAS’s active and ongoing scientific activity and its contribution to the development of knowledge in the field of experimental medicine.
